Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Epithelial Cancer Recurrent × Trabectedin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Sarcoma 19 Ovarian Neoplasms 7 Leiomyosarcoma 5 Liposarcoma 4 Liposarcoma, Myxoid 3 Sarcoma, Ewing 2 Osteosarcoma 2 Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Epithelial Cancer Recurrent 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leiomyosarcoma Uterus 1 Ichthyosis, X-Linked 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1 Fanconi Anemia, Complementation Group D1 1 Chondrosarcoma 1 Carcinosarcoma 1 Cancers With DNA Repair-Deficiency 1 Bone Neoplasms 1

Interventions

liposomal doxorubicin 1 Trabectedin 1 Hyperthermic Intraperitoneal Chemotherapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡